The 2018 Congressional midterm elections are over: the US is back to divided government. And with Democrats controlling the House, and Republicans expanding their majority in the Senate, the US pharma industry could be the number one target for politicians.
0
min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.